Molecular Mechanism of Cyclin E1 in Lung Adenocarcinoma and Their Cellular Response

被引:0
|
作者
Zhao, Ming [1 ]
Tian, Qing [1 ]
Qiu, Yonghui [1 ]
Pei, Yanbin [1 ]
Wang, Yuqi [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Thorac Surg, Med Ctr 1, 28 Fuzing Rd, Beijing 100853, Peoples R China
关键词
y Lung Adenocarcinoma; CCNE1; METTL3; Cell Proliferation; STATISTICS; EXPRESSION; SURVIVAL; CCNE1;
D O I
10.1166/jbn.2023.3549
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The purpose of this study was to explore the role and molecular mechanism of CCNE1 in lung adenocarcinoma (LUAD). CCNE1 expression was analyzed in LUAD tissues and cell lines by GEPIA and qRT-PCR, and its correlation with patient survival was studied using TCGA. CCNE1 overexpression was tested for its effects on cellular functions. METTL3 was predicted as a downstream gene of CCNE1 and their correlation was analyzed in lung adenocarcinoma. MeRIP was used to measure the m6A level of CCNE1 mRNA 3'-UTR after METTL3 overexpression. Dual luciferase reporter gene experiments were conducted to determine the effect of METTL3 knockdown on CCNE1 activity. Recovery experiments were performed to evaluate the CCNE1-METTL3 regulation. CCNE1 was up-regulated in LUAD cells and tissues and linked to patient prognosis. Highly expressed CCNE1 increased LUAD proliferation. METTL3 was also highly expressed in LUAD tissues and positively correlated with CCNE1 expression. METTL3 reduced CCNE1 methylation and increased expression. Additionally, METTL3 overexpression partially reversed the inhibitory effect of CCNE1 silencing on LUAD cell proliferation. This study found that CCNE1 was markedly overexpressed in lung adenocarcinoma. METTL3 can inhibit the IP: 203 8 109 20 On: Tue 27 Jun 2023 11:35:48 methylation level of CCNE1. Highly expressed CCNE1 can promote he proliferation of lung adenocarcinoma. Copyright: American Scientific Publishers
引用
收藏
页码:449 / 456
页数:8
相关论文
共 50 条
  • [21] Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells
    Caldon, C. Elizabeth
    Sergio, C. Marcelo
    Sutherland, Robert L.
    Musgrove, Elizabeth A.
    CELL CYCLE, 2013, 12 (04) : 596 - 605
  • [22] PROPERTIES OF FLUORESCENCE PROBE RESPONSE ASSOCIATED WITH TRANSMISSION MECHANISM OF COLICIN E1
    PHILLIPS, SK
    CRAMER, WA
    BIOCHEMISTRY, 1973, 12 (06) : 1170 - 1176
  • [23] Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway
    Liu, Zhiqiang
    Li, Yongfeng
    Li, Xiaogang
    Zhao, Jingyuan
    Wu, Shihong
    Wu, Heshui
    Gou, Shanmiao
    MOLECULAR THERAPY-ONCOLYTICS, 2020, 17 : 21 - 30
  • [24] Selective Targeting of Cyclin E1 Using Molecular Glue Degraders in CCNE1 Amplified Solid Malignancies
    Ilic-Widlund, N.
    Tahaney, W.
    Liu, Y.
    Gkountela, S.
    Quan, C.
    Lucas, X.
    Emil, N.
    Diesslin, A.
    King, C.
    Dubois, A.
    Osmont, A.
    Zlotosch, M.
    Bianda, C.
    Alers, J.
    Demarco, B.
    Warmuth, M.
    Townson, S.
    Fasching, B.
    Ranieri, B.
    Tiedt, R.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S182 - S183
  • [25] Cyclin E1 is a prognostic biomarker and potential therapeutic target in osteosarcoma
    Wei, Ran
    Thanindratarn, Pichaya
    Dean, Dylan C.
    Hornicek, Francis J.
    Guo, Wei
    Duan, Zhenfeng
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2020, 38 (09) : 1952 - 1964
  • [26] Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse
    Corvaisier, Matthieu
    Bauzone, Marjolaine
    Corfiotti, Francois
    Renaud, Florence
    El Amrani, Mehdi
    Monte, Didier
    Truant, Stephanie
    Leteurtre, Emmanuelle
    Formstecher, Pierre
    Van Seuningen, Isabelle
    Gespach, Christian
    Huet, Guillemette
    ONCOTARGET, 2016, 7 (35) : 56699 - 56712
  • [27] TARGETING LIVER FIBROSIS BY RNAI - MEDIATED INHIBITION OF CYCLIN E1
    Bangen, J-M
    Hammerich, L.
    Sonntag, R.
    Haas, U.
    Lambertz, D.
    Tacke, F.
    Trautwein, C.
    Liedtke, C.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S708 - S709
  • [28] ON MECHANISM OF BIOSYNTHESIS OF PROSTAGLANDINS E1 AND F
    HAMBERG, M
    SAMUELSS.B
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1967, 242 (22) : 5336 - &
  • [29] Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets
    Milioli, H. H.
    Alexandrou, S.
    Lim, E.
    Caldon, C. E.
    ENDOCRINE-RELATED CANCER, 2020, 27 (05) : R93 - R112
  • [30] PROGNOSTIC IMPORTANCE OF CYCLIN E1 EXPRESSION IN NEUROBLASTIC TUMORS IN CHILDREN
    Taran, Katarzyna
    Owecka, Agata
    Kobos, Jozef
    POLISH JOURNAL OF PATHOLOGY, 2013, 64 (02) : 149 - 152